✦ LIBER ✦

Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer

✍ Scribed by Mohammad Jahanzeb

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN61 COST-EFFECTIVENESS OF 1-YEAR ADJUV

✍ T.T.T. Nguyen; R. Yagudina; A.U. Kulikov 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN4 BUDGET IMPACT ANALYSIS OF ADJUVANT

✍ E Orlewska; R Aultman; M Krzakowski; T Pienkowski; K Drosik; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJU

✍ E Orlewska; T Pienkowski; K Drosik; M Gyldmark; R Aultman; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Adjuvant trastuzumab for HER2-positive b

✍ James Spicer; Mark Harries; Paul Ellis 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 47 KB

263 ORAL Doxorubicin and cyclophosphamid

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

An Economic Evaluation of Adjuvant Trast

✍ Wen Chen; Zefei Jiang; Zhimin Shao; Qiang Sun; Kunwei Shen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB